September 9, 2026
Expert Warns of Hidden Crisis in UTI Diagnosis, Underscoring Need for Advanced Testing
September 9, 2026
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15
September 9, 2026
Quantum BioPharma’s Lucid-MS Gains FDA Clearance for Phase 2 Trial, Drawing Analyst Buy Rating
September 9, 2026
GeoVax Welcomes Global Mpox Vaccine Stockpile, Highlights GEO-MVA’s Role in Diversifying Supply
September 8, 2026
VERAXA Biotech Appoints Raju Willener as CFO to Drive Capital Strategy and Pipeline Growth
September 8, 2026
Scinai Immunotherapeutics Streamlines Operations to Prioritize NanoAb Platform and CDMO Growth
September 8, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing and Capital Milestones
September 8, 2026
Quantum BioPharma Gets FDA Clearance for Phase 2 Trial of First-in-Class MS Drug Candidate
September 8, 2026
Ocumetics Begins Patient Recruitment for Group Two Clinical Surgeries of Its Accommodating Intraocular Lens
September 8, 2026
Quantum BioPharma Gets FDA Green Light for First-in-Class MS Drug Targeting Myelin Repair
September 8, 2026
Quantum BioPharma’s Lucid-MS Gets FDA Clearance for Phase 2 Trial in Multiple Sclerosis
September 8, 2026
Quantum BioPharma Gains FDA Clearance for Lucid-MS Phase 2 Trial in Multiple Sclerosis
September 8, 2026
Quantum BioPharma Cleared to Begin Phase 2 Trial of Lucid-MS for Multiple Sclerosis
September 8, 2026
Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer Amid TONMYA Launch
September 4, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Key Manufacturing Milestones
September 3, 2026
OS Therapies to Present at Moody Capital Conference Amid Key Regulatory Milestones for OST-HER2
September 3, 2026
Immunotherapy Before Surgery May Improve Glioblastoma Outcomes, Preclinical Study Finds
September 2, 2026
FDA Criticized for Inaction as Black Market for Unapproved Weight-Loss Drug Retatrutide Flourishes Online
September 2, 2026
Protecting the Thymus During Lung Cancer Treatment Could Improve Outcomes, Study Finds
September 1, 2026
NurExone Biologic to Present Exosome Platform and U.S. Strategy at New York Conference
September 1, 2026
CNS Pharmaceuticals Outlines Business Development Strategy to Expand Pipeline in Oncology and Neurology
September 1, 2026
Harrisburg Hematologist Dr. Salman Fazal Earns Third Consecutive Castle Connolly Top Doctor Honor
August 31, 2026
NanoViricides Advances NV-387 Measles Treatment Toward Phase II Trial Amid Rising Cases
August 31, 2026
TransCode Therapeutics Reports Survival Benefit in Preclinical Breast Cancer Bone Metastasis Study
August 30, 2026
Nurse’s Metastatic Breast Cancer Journey Highlights Importance of New Treatment Options
August 28, 2026
New Study Challenges Core Safety Assumption of Electroshock Therapy, CCHR Renews Ban Calls
August 26, 2026
Heidelberg Pharma and Huadong Medicine Secure NMPA Approval for HDP-101 Combination Trial in China
August 25, 2026
Lakewood-Amedex Biotherapeutics Partners with B2i Digital Ahead of Phase 2a Trial for Infected Diabetic Foot Ulcers
August 25, 2026
Citius Pharmaceuticals Leverages FDA-Approved LYMPHIR and Late-Stage Pipeline to Drive Growth
August 24, 2026
VERAXA and Secarna Report Positive Early Data in Antibody-Oligonucleotide Collaboration
August 24, 2026
VERAXA Biotech Advances VXA-222 Cancer Program Beyond Discovery Phase, Strengthens IP Portfolio
August 24, 2026
Scinai Immunotherapeutics Reports H1 2026 Results, Advances U.S. Clinical Manufacturing Program
August 23, 2026
Mitochondrial Transplantation During Machine Perfusion Shows Promise for Repairing Donor Organs
August 23, 2026
New Seven Up Score Could Spare One in Three Liver Transplant Patients from Unnecessary Steroid Treatment
August 19, 2026
Quantum BioPharma’s Lucid-MS Targets Myelin Protection as New Approach to MS Treatment
